The Relationship between Vascular Function and the Autonomic Nervous System.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 4072858)

Published in Ann Vasc Dis on May 16, 2014

Authors

Eisuke Amiya1, Masafumi Watanabe1, Issei Komuro1

Author Affiliations

1: Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Articles cited by this

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53

Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation (1999) 8.92

Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation (1996) 6.20

Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation (2006) 5.91

Atherosclerosis is an inflammatory disease. Am Heart J (1999) 5.12

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry (1998) 4.83

Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation (2008) 4.69

Neural control of renal function. Physiol Rev (1997) 4.00

A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord (2005) 2.96

Obesity-associated hypertension: new insights into mechanisms. Hypertension (2004) 2.86

Effects of the cold pressor test on muscle sympathetic nerve activity in humans. Hypertension (1987) 2.46

Mental stress induces transient endothelial dysfunction in humans. Circulation (2000) 2.37

Sympathetic neural activation in visceral obesity. Circulation (2002) 2.34

Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature (1988) 2.27

Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension (2010) 2.01

Adventitial remodeling after coronary arterial injury. Circulation (1996) 1.94

Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension (2009) 1.79

The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med (2001) 1.77

The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res (2007) 1.74

Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain (1984) 1.69

Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol (2002) 1.68

Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol (2007) 1.64

Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res (1998) 1.62

Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes (2002) 1.62

The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev (2003) 1.62

Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998. Circulation (2003) 1.61

Active participation of endothelial cells in inflammation. J Leukoc Biol (2005) 1.61

Insulin resistance and sympathetic overactivity in women. J Hypertens (2006) 1.59

Leukocyte-endothelial interactions in inflammation. J Cell Mol Med (2009) 1.51

Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation (2004) 1.47

Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res (2000) 1.46

Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res (1990) 1.37

Dissociation of sympathetic nerve activity in arm and leg muscle during mental stress. Hypertension (1987) 1.32

Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes (1997) 1.30

Interactions between autonomic nervous system activity and endothelial function: a model for the development of cardiovascular disease. Psychosom Med (2004) 1.29

Interactions among higher trait anxiety, sympathetic activity, and endothelial function in the elderly. J Psychiatr Res (2006) 1.23

Reliable endothelial function testing: at our fingertips? Circulation (2008) 1.21

Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. J Neurosci (1998) 1.21

Role of nitric oxide in central sympathetic outflow. Exp Biol Med (Maywood) (2001) 1.20

An evolving new paradigm: endothelial cells--conditional innate immune cells. J Hematol Oncol (2013) 1.17

Role of nitric oxide in the neural control of cardiovascular function. Cardiovasc Res (1999) 1.14

Local mechanisms of blood flow control by perivascular nerves and endothelium. J Hypertens Suppl (1990) 1.13

Flow-mediated vasodilation as a diagnostic modality for vascular failure. Hypertens Res (2008) 1.12

Vascular dysfunction and autonomic neuropathy in Type 2 diabetes. Diabet Med (2004) 1.10

Role of nNOS in blood pressure regulation in eNOS null mutant mice. Hypertension (1998) 1.10

Sympathetic regulation of vascular function in health and disease. Front Physiol (2012) 1.07

Large brachial artery diameter is associated with angiographic coronary artery disease in women. Am Heart J (2002) 1.06

Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease. Am Heart J (2000) 1.05

Nonadrenergic neural vasodilator mechanisms. Circ Res (1987) 1.04

Relation of inflammation to vascular function in patients with coronary heart disease. Atherosclerosis (2000) 1.01

Differential effect of experimental hypertension and hypercholesterolemia on adventitial remodeling. Arterioscler Thromb Vasc Biol (2004) 1.01

Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukoc Biol (2000) 1.00

Psychosocial stress causes endothelial injury in cynomolgus monkeys via beta1-adrenoceptor activation. Atherosclerosis (1998) 1.00

A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study. J Am Coll Cardiol (2000) 0.97

Sympathetic nervous system contributes to the age-related impairment of flow-mediated dilation of the superficial femoral artery. Am J Physiol Heart Circ Physiol (2006) 0.97

Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. J Hypertens (2007) 0.97

Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension (1995) 0.96

The neurotransmitter dopamine modulates vascular permeability in the endothelium. J Mol Signal (2008) 0.96

Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans. Circulation (1997) 0.96

Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes. Diabetes Care (2012) 0.95

Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease. Am J Cardiol (2005) 0.95

Long-term renal denervation normalizes disrupted blood pressure circadian rhythm and ameliorates cardiovascular injury in a rat model of metabolic syndrome. J Am Heart Assoc (2013) 0.94

Relationship between heart rate variability, blood pressure and arterial wall properties during air and oxygen breathing in healthy subjects. Auton Neurosci (2013) 0.94

Sympathetic activation and nitric oxide function in early hypertension. Am J Physiol Heart Circ Physiol (2012) 0.93

Plasma norepinephrine is an independent predictor of vascular endothelial function with aging in healthy women. J Appl Physiol (1985) (2011) 0.93

The interaction of CGRP and adrenomedullin with a receptor expressed in the rat pulmonary vascular endothelium. J Mol Endocrinol (1997) 0.91

Immunohistochemical detection of calcitonin gene-related peptide receptor (CGRPR)-1 in the endothelium of human coronary artery and bronchial blood vessels. Neuropeptides (2001) 0.90

Risk factors for progression of distal symmetric polyneuropathy in type 1 diabetes mellitus. Sorbinil Retinopathy Trial Research Group. Am J Epidemiol (1999) 0.88

Effect of removal of adventitia on vascular smooth muscle contraction and relaxation. Am J Physiol Heart Circ Physiol (2001) 0.87

Non-synaptic transmission at autonomic neuroeffector junctions. Neurochem Int (2007) 0.87

Mortality among outpatients with anxiety disorders. Am J Psychiatry (1986) 0.87

Neurally released ATP mediates endothelium-dependent hyperpolarization in the circular smooth muscle cells of chicken anterior mesenteric artery. Br J Pharmacol (2005) 0.87

Simultaneous heart rate variability monitoring enhances the predictive value of flow-mediated dilation in ischemic heart disease. Circ J (2012) 0.86

Involvement of the peripheral sensory and sympathetic nervous system in the vascular endothelial expression of ICAM-1 and the recruitment of opioid-containing immune cells to inhibit inflammatory pain. Brain Behav Immun (2010) 0.86

Flow-mediated vasodilation and endothelium function in children with postural orthostatic tachycardia syndrome. Am J Cardiol (2010) 0.86

Endothelial NO synthase polymorphisms and postural tachycardia syndrome. Hypertension (2005) 0.85

Muscle sympathetic nerve activity is related to a surrogate marker of endothelial function in healthy individuals. PLoS One (2010) 0.85

Increased pulse-wave velocity in patients with anxiety: implications for autonomic dysfunction. J Psychosom Res (2006) 0.84

Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor. Diabetes Metab Res Rev (2003) 0.84

The effect of moxonidine on endothelial dysfunction in metabolic syndrome. Am J Cardiovasc Drugs (2006) 0.84

Sympathetic overactivity, endothelial dysfunction, inflammation, and metabolic abnormalities cluster in grade III (World Health Organization) obesity: reversal through sustained weight loss obtained with laparoscopic adjustable gastric banding. Diabetes Care (2006) 0.83

Angiotensin II impairs endothelial nitric-oxide synthase bioavailability under free cholesterol-enriched conditions via intracellular free cholesterol-rich membrane microdomains. J Biol Chem (2013) 0.83

Effect of nitric oxide on excitatory amino acid-evoked discharge of neurons in NTS. Am J Physiol Heart Circ Physiol (2003) 0.81

Brachial artery diameter changes associated with cardiopulmonary baroreflex activation in humans. Am J Physiol (1990) 0.79

Effects of doxazosin and atenolol on circulating endothelin-1 and von Willebrand factor in hypertensive middle-aged men. J Cardiovasc Pharmacol (1999) 0.78

Recent evidence for the involvement of catecholamines and of macrophages in atherosclerotic processes. Ann Med (1991) 0.78

Cyclic GMP modulators on vascular adrenergic neurotransmission. J Vasc Res (1992) 0.78

Intense exercise causes decrease in expression of both endothelial NO synthase and tissue NOx level in hearts. Am J Physiol Regul Integr Comp Physiol (2000) 0.78

Do cholinergic nerves innervating rat mesenteric arteries regulate vascular tone? Am J Physiol Regul Integr Comp Physiol (2012) 0.78

Determinants of signal transmission in healthy and diseased autonomic neuromuscular junctions. Diabet Med (1993) 0.76

Catecholamines stimulate the IFN-gamma-induced class II MHC expression on bovine brain capillary endothelial cells. J Immunol (1991) 0.76

[Role of the adventitial innervation in establishing and maintaining the structural and functional properties of the arterial wall. Effects during aging]. Ann Cardiol Angeiol (Paris) (1991) 0.76

Presence of desaturated hemoglobin enhances the contribution of blood cells to flow-mediated dilation in subjects with systemic sclerosis. Int J Cardiol (2013) 0.76

Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function. Diabetologia (1996) 0.75

Differences in neuropeptide Y-induced secretion of endothelin-1 in left and right human endocardial endothelial cells. Neuropeptides (2012) 0.75

Sympathetic vascular function in patients with central dysautonomia. J Neural Transm Suppl (1991) 0.75

Articles by these authors

Modulation of cardiac fibrosis by Krüppel-like factor 6 through transcriptional control of thrombospondin 4 in cardiomyocytes. Cardiovasc Res (2015) 1.43

The ω-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling. PLoS One (2014) 0.89

Significance of imbalance in the ratio of serum n-3 to n-6 polyunsaturated fatty acids in patients with acute coronary syndrome. Am J Cardiol (2013) 0.86

A deletion mutation in myosin heavy chain 11 causing familial thoracic aortic dissection in two Japanese pedigrees. Int J Cardiol (2015) 0.82

The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension. Hypertens Res (2016) 0.82

Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity. Cardiovasc Res (2016) 0.80

Elevated C-reactive protein levels and enhanced high frequency vasomotion in patients with ischemic heart disease during brachial flow-mediated dilation. PLoS One (2014) 0.77

Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan. J Cardiol (2014) 0.77

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study. Hypertens Res (2016) 0.75

A Food-Derived Flavonoid Luteolin Protects against Angiotensin II-Induced Cardiac Remodeling. PLoS One (2015) 0.75

Different Contributions of Physical Activity on Arterial Stiffness between Diabetics and Non-Diabetics. PLoS One (2016) 0.75

Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure. PLoS One (2017) 0.75

Quantitative Measurement of GPCR Endocytosis via Pulse-Chase Covalent Labeling. PLoS One (2015) 0.75

Donor age is a predictor of early low output after heart transplantation. J Cardiol (2015) 0.75

Successful bridge to recovery in fulminant myocarditis using a biventricular assist device: a case report. J Med Case Rep (2017) 0.75

Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure. Korean Circ J (2017) 0.75

Incidence and long-term outcome of heart transplantation patients who develop postoperative renal failure requiring dialysis. J Heart Lung Transplant (2021) 0.75

Impact of serum lactate dehydrogenase on the short-term prognosis of COVID-19 with pre-existing cardiovascular diseases. J Cardiol (2021) 0.75

Phenotypic differences in aortic stenosis according to calcification grade. Int J Cardiol (2016) 0.75